BASEL, SWITZERLAND @ The recent EU Variations Regulation that took effect in January is expected to simplify and future-proof the process for implementing manufacturing changes for medicinal products, according to Mónica Perea-Vélez, CMC advocacy and policy director at GSK, who spoke at DIA Europe 2025 on 19 March. @Read More
DIA Europe: Variations regulation expected to ease postapproval changes for pharmaceuticals
